Viewing Study NCT03971461


Ignite Creation Date: 2025-12-24 @ 12:04 PM
Ignite Modification Date: 2026-01-21 @ 11:24 PM
Study NCT ID: NCT03971461
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-22
First Post: 2019-05-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma
Sponsor: NYU Langone Health
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module